This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of Pittsburgh, University of Exeter. Active years: 2021-2024.
Company Filing History:
3 out of 955 
3 out of 1,959 
2 out of 34 Years Active: 2021-2024
Title: The Innovations of Dandan Sun: A Focus on Neuroprotective Solutions
Introduction
Dandan Sun, based in Pittsburgh, PA, is an accomplished inventor with a significant impact on the field of neuropharmacology. With a total of three patents to her name, she has dedicated her research efforts to addressing some of the most challenging neurodegenerative and neurocognitive disorders that affect millions worldwide.
Latest Patents
Among Dandan Sun's latest patents is the innovative use of ZT-1A and its analogs for the prevention and treatment of neurodegenerative and neurocognitive disorders. This patent outlines substituted N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds. These compounds show potential in treating several conditions, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and various forms of dementia.
Another significant patent by Dandan Sun focuses on SPAK kinase inhibitors as neuroprotective agents. This patent details the use of N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds, which inhibit SPAK kinase function. These compounds could provide therapeutic benefits for individuals suffering from hypoxic brain injuries, particularly those resulting from ischemic strokes.
Career Highlights
Dandan Sun has had a meaningful career marked by collaboration with prominent institutions. She has worked for the United States of America as represented by the Department of Veterans Affairs and the University of Pittsburgh. Her role in these esteemed organizations has allowed her to contribute to critical research in the field of neuropharmacology.
Collaborations
In her journey as an inventor, Dandan has collaborated with talented coworkers such as Mohammad Iqbal Hossain Bhuiyan and Xianming Deng. These partnerships have not only enhanced her research capabilities but have also furthered the collective mission to advance neuroprotective treatments.
Conclusion
Dandan Sun's innovative contributions to neuropharmacology showcase her dedication to improving health outcomes for individuals affected by neurodegenerative disorders. With her patents focusing on neuroprotective agents, she continues to pave the way for groundbreaking treatments, highlighting the importance of research and collaboration in the journey of scientific discovery.